glp-1/gip dual agonist Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Upcoming wave of hormone-based therapies
Description
For non-alcoholic beverage brands, the game plan seems clear: Invest in flavor innovation that cuts through dulled taste buds
GLP-1 (glucagon-like peptide-1) receptor agonists are drugs that act like a natural hormone in the body
You may also begin to notice changes in your appetite and weight
BBC Science Focus (2023)
Furthermore, on February 2025, Biocon Limited , an innovation-driven global biopharmaceutical business, has announced the launch of Liraglutide, a GLP-1 peptide for diabetes and obesity, in the United Kingdom
doi: 10.4254/wjh.v7.i10.1297
